Prevention of CKD in patients with renal stone disease - à¹à¸£à¸à¸à¸¢à¸²à¸à¸²à¸¥ ...

More documents

Recommendations

Info

Glycemic Control – Intervention StudiesMicro- and Macrovascular ComplicationsReduction in risk with intensive therapyRetinopathyNephropathyNeuropathyCardiovasculardiseaseDCCT(Type 1)63%54%60%41%*Kumamoto(Type 2)69%70%--UKPDS(Type 2)17-21%24-33%-16%*DCCT Research Group. N Engl J Med. . 1993;329:977-986.986.Ohkubo Y, et al. Diabetes Res Clin Pract. . 1995;28:103-117.117.UKPDS 33: Lancet 1998; 352, 837-853.853.16
Target of Glycemic Control HbA1c < 7.0% Preprandial capillary plasma glucose90 - 130 mg/dl (5.0 - 7.2 mmol/l) Peak postprandial capillary plasma glucose< 180 mg/dl (
Page 1 and 2: Update on CKD PreventionStrategies
Page 3 and 4: Etiology of End-Stage Renal Disease
Page 5 and 6: Natural History of DNCardiovascular
Page 9 and 10: Risk factors for DN Poor glycemic c
Page 12 and 13: American Diabetic Association2005 (
Page 14 and 15: Microalbuminuria (MAU) ทําก
Page 18 and 19: HBA1c ผูปวยที่ค
Page 20 and 21: Meta Analysis: Lower systolic BP re
Page 22 and 23: Hypertension control ในผู
Page 24 and 25: Goal BP Recommendations for Patient
Page 26 and 27: SummaryType 1 DMNormo-albuminuriaTy
Page 28 and 29: Hyperlipidemiaอายุผูป
Page 30 and 31: งดสูบบุหรี่Sm
Page 32: ขอบคุณครับ

Prevention of CKD in patients with renal stone disease - à¹à¸£à¸à¸à¸¢à¸²à¸à¸²à¸¥ ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?

Prevention of CKD in patients with renal stone disease - à¹à¸£à¸à¸à¸¢à¸²à¸à¸²à¸¥ ...